Brokerages Set Henry Schein, Inc. (NASDAQ:HSIC) PT at $76.08

Henry Schein, Inc. (NASDAQ:HSIC) has received an average recommendation of “Hold” from the fourteen brokerages that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $76.0769.

A number of equities analysts have issued reports on the company. Wall Street Zen upgraded Henry Schein from a “hold” rating to a “buy” rating in a research report on Saturday. Weiss Ratings restated a “hold (c-)” rating on shares of Henry Schein in a research report on Friday, October 31st. Morgan Stanley increased their target price on Henry Schein from $55.00 to $58.00 and gave the company an “underweight” rating in a research report on Wednesday, November 5th. Wells Fargo & Company lifted their price target on shares of Henry Schein from $70.00 to $76.00 and gave the company an “equal weight” rating in a research note on Wednesday, November 5th. Finally, Baird R W lowered shares of Henry Schein from a “strong-buy” rating to a “hold” rating in a report on Monday, July 14th.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. CYBER HORNET ETFs LLC purchased a new position in Henry Schein in the 2nd quarter valued at about $25,000. MUFG Securities EMEA plc acquired a new position in shares of Henry Schein during the second quarter valued at approximately $27,000. ANTIPODES PARTNERS Ltd purchased a new position in shares of Henry Schein in the second quarter valued at approximately $43,000. Steph & Co. purchased a new position in shares of Henry Schein in the second quarter valued at approximately $44,000. Finally, CX Institutional boosted its stake in shares of Henry Schein by 107.3% in the second quarter. CX Institutional now owns 651 shares of the company’s stock worth $48,000 after acquiring an additional 337 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Stock Up 2.6%

HSIC stock opened at $71.90 on Friday. Henry Schein has a one year low of $60.56 and a one year high of $82.49. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. The firm’s fifty day moving average is $66.30 and its 200 day moving average is $68.76. The firm has a market cap of $8.46 billion, a PE ratio of 23.19, a P/E/G ratio of 2.06 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, November 4th. The company reported $1.38 earnings per share for the quarter, topping analysts’ consensus estimates of $1.27 by $0.11. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The business had revenue of $3.34 billion during the quarter, compared to the consensus estimate of $3.28 billion. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. On average, research analysts forecast that Henry Schein will post 4.74 EPS for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.